|
||||||||||||||||||||||||||||||
![]()
CAS号:145918-75-8
|
英文名称:TROXACITABINE
分子式
C8H11N3O4
分子量
213
EINECS号
200-258-5
MDL
MFCD00871100
Smiles
InChIKey
乙二醇化学百科
基本信息
物化性质
安全信息
生产及用途
Troxacitabine是一种具有强效抗肿瘤活性的二氧戊环类似物。 Troxacitabine has shown cutotoxicity in cancer cell lines of hepatocellular (HepG2), prostate (PC3, DUI45), non-small cell lung (NCI-H460, NCr-322M) colon (HT29), renal (CAK-l, A498, RXF-393, SNI2-C) and pancreatic origin (Pnac-Ol, MiaPa Ca) with IC 50 s range from 15-35 μM.
Troxacitabine is highly active against the Panc-01 model, with TGI levels of 88.5% and 84.3% at the 10 and 25 mg/kg doses, respectively. The mean final tumor weights for animals given troxacitabine are also significantly smaller compared with vehicle controls. Troxacitabine has less activity against the MiaPaCa model. Troxacitabine is very effective in human RCC tumor xenograft models, including CAM-i, A498, RXF-393, and SN12C carcinomas. Very good responses are ob served in animals bearing CAM-i, A498, and RXF-393 RCC tumors given i.p. doses of 10, 25, and 50 mg/kg twice a day for 5 days.
上下游产品
上游产品共计:0个
下游产品共计:0个
相关产品
产品供应商
|
||||||||||||||||||||||||||||||